Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia

This study has been completed.
Sponsor:
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01388283
First received: June 30, 2011
Last updated: July 5, 2011
Last verified: June 2011
  Purpose

The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.


Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Biospecimen Retention:   Samples Without DNA

serum


Enrollment: 129
Study Start Date: January 1999
Study Completion Date: June 2011
Primary Completion Date: May 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   20 Years to 43 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Case-control study consisting of 43 women developping preeclampsia and 86 women not developping this disorder. All were of Caucasian origin and were nulliparous.

Criteria

Inclusion Criteria:

  • caucasian,
  • nulliparous

Exclusion Criteria:

  • preexisting cardiovascular diseases,
  • diabetes,
  • hypertension,
  • inflammatory bowel diseases,
  • serious organ diseases, and
  • development of separate gestational diabetes and/or hypertension.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Oslo University Hospital, Department of Medical Biochemistry
ClinicalTrials.gov Identifier: NCT01388283     History of Changes
Other Study ID Numbers: INMARPE11
Study First Received: June 30, 2011
Last Updated: July 5, 2011
Health Authority: Norway:The Data Inspectorate
Norway: Directorate of Health

Keywords provided by Oslo University Hospital:
prognostic marker

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on October 22, 2014